[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate

C34H50NO4- — CID 163145811

IUPAC[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate
SMILESCC(C)CCC[C@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OC(=O)c5cccc(N([O-])O)c5)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H50NO4/c1-22(2)8-6-9-23(3)29-14-15-30-28-13-12-25-21-27(16-18-33(25,4)31(28)17-19-34(29,30)5)39-32(36)24-10-7-11-26(20-24)35(37)38/h7,10-12,20,22-23,27-31,37H,6,8-9,13-19,21H2,1-5H3/q-1/t23-,27+,28-,29+,30-,31-,33-,34+/m0/s1
InChIKeyLGVATSZEIZVTBO-MOTKLJEASA-N
MW536.78 g/mol
LogP8.95
Rot. Bonds8

About [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate

[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate (PubChem CID 163145811) has the molecular formula C34H50NO4- and a molecular weight of 536.78 g/mol. Its IUPAC name is [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate.

Molecular Properties

Compound Name[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate
PubChem CID163145811
Molecular FormulaC34H50NO4-
Molecular Weight536.78 g/mol
Exact Mass536.37
IUPAC Name[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate
SMILESCC(C)CCC[C@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OC(=O)c5cccc(N([O-])O)c5)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C34H50NO4/c1-22(2)8-6-9-23(3)29-14-15-30-28-13-12-25-21-27(16-18-33(25,4)31(28)17-19-34(29,30)5)39-32(36)24-10-7-11-26(20-24)35(37)38/h7,10-12,20,22-23,27-31,37H,6,8-9,13-19,21H2,1-5H3/q-1/t23-,27+,28-,29+,30-,31-,33-,34+/m0/s1
InChIKeyLGVATSZEIZVTBO-MOTKLJEASA-N
XLogP8.95
TPSA72.83 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500536.78
LogP ≤ 58.95
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate?
The IUPAC name of [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate (CID 163145811) is [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate.
What is the SMILES notation for [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate?
The canonical SMILES for [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate is CC(C)CCC[C@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OC(=O)c5cccc(N([O-])O)c5)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate?
The InChIKey is LGVATSZEIZVTBO-MOTKLJEASA-N. The full InChI is InChI=1S/C34H50NO4/c1-22(2)8-6-9-23(3)29-14-15-30-28-13-12-25-21-27(16-18-33(25,4)31(28)17-19-34(29,30)5)39-32(36)24-10-7-11-26(20-24)35(37)38/h7,10-12,20,22-23,27-31,37H,6,8-9,13-19,21H2,1-5H3/q-1/t23-,27+,28-,29+,30-,31-,33-,34+/m0/s1.
What are the key properties of [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate?
[(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate has a molecular weight of 536.78 g/mol, XLogP of 8.95, 8 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-[hydroxy(oxido)amino]benzoate is sourced from PubChem (CID 163145811), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).